Cardiac MRI and blood markers sharpen hypertrophic cardiomyopathy risk prediction

AI Summary

A new study reveals a model for predicting outcomes in patients with hypertrophic cardiomyopathy (HCM). By integrating clinical history, imaging, and blood biomarker data, the model enhances the prediction of adverse cardiac events for individuals with this serious heart condition.

Findings from a new study have identified a new model for predicting outcomes for hypertrophic cardiomyopathy (HCM), a heart condition with a prevalence of one in 500 people and a frequent cause of sudden cardiac death. Specifically, the findings demonstrate that incorporating prospective data including clinical history, imaging, and blood biomarker data into risk assessment can improve prediction of adverse cardiac events in people with HCM.